Circulating let-7 Levels in Serum Correlate With the Severity of Hepatic Fibrosis in Chronic Hepatitis C
- PMID: 30443558
- PMCID: PMC6231525
- DOI: 10.1093/ofid/ofy268
Circulating let-7 Levels in Serum Correlate With the Severity of Hepatic Fibrosis in Chronic Hepatitis C
Abstract
Background: Evaluating the progression of hepatic fibrosis in chronic hepatitis C (CHC) is critical, and identifying a predictive biomarker for fibrosis will be helpful for implementing personalized surveillance of hepatocellular carcinoma after the elimination of hepatitis C virus by antiviral therapy. This study aimed to investigate the association of circulating let-7a-5p levels with severity of hepatic fibrosis.
Methods: We analyzed circulating let-7a-5p levels in serum and serum-derived extracellular vesicles (EVs) in 84 Japanese CHC patients who underwent a liver biopsy by quantitative real-time polymerase chain reaction, and investigated the association of its levels with histological hepatic fibrotic stage, liver stiffness, and several hepatic fibrotic markers.
Results: The levels of let-7a-5p in serum and EVs were significantly lower in patients with liver cirrhosis. Additionally, the serum let-7a-5p level correlated significantly with hepatic fibrotic markers, Mac-2 binding protein glycan isomer (M2BPGi), fibrosis-4 (FIB-4) index, aspartate aminotransferase-to-platelet ratio index (APRI), and liver stiffness, evaluated by transient elastography. Furthermore, the serum let-7a-5p level was superior to M2BPGi, FIB-4, and APRI and was comparable to liver stiffness in discriminating liver cirrhosis.
Conclusions: These results provide evidence that circulating let-7a-5p in serum may serve as a surrogate marker for severity of hepatic fibrosis in CHC.
Keywords: extracellular vesicles; hepatic fibrosis; hepatitis C virus; let-7; microRNA.
Figures

Similar articles
-
Circulating let-7 levels in plasma and extracellular vesicles correlate with hepatic fibrosis progression in chronic hepatitis C.Hepatology. 2016 Sep;64(3):732-45. doi: 10.1002/hep.28660. Epub 2016 Jul 7. Hepatology. 2016. PMID: 27227815 Free PMC article.
-
Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients.J Formos Med Assoc. 2015 Oct;114(10):923-8. doi: 10.1016/j.jfma.2015.07.004. Epub 2015 Aug 13. J Formos Med Assoc. 2015. PMID: 26279173
-
Accuracy of M2BPGi, compared with Fibro Scan®, in analysis of liver fibrosis in patients with hepatitis C.BMC Gastroenterol. 2017 May 10;17(1):62. doi: 10.1186/s12876-017-0618-5. BMC Gastroenterol. 2017. PMID: 28486931 Free PMC article.
-
Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis.J Gastroenterol. 2018 Jul;53(7):819-826. doi: 10.1007/s00535-017-1425-z. Epub 2018 Jan 9. J Gastroenterol. 2018. PMID: 29318378 Review.
-
M2BPGi for assessing liver fibrosis in patients with hepatitis C treated with direct-acting antivirals.World J Gastroenterol. 2020 Jun 7;26(21):2864-2876. doi: 10.3748/wjg.v26.i21.2864. World J Gastroenterol. 2020. PMID: 32550761 Free PMC article.
Cited by
-
Circulating Let-7 Family Members as Non-Invasive Biomarkers for Predicting Hepatocellular Carcinoma Risk after Antiviral Treatment among Chronic Hepatitis C Patients.Cancers (Basel). 2022 Apr 16;14(8):2023. doi: 10.3390/cancers14082023. Cancers (Basel). 2022. PMID: 35454929 Free PMC article.
-
Exercise-induced circulating exosomes potentially prevent pelvic organ prolapse in clinical practice via inhibition of smooth muscle apoptosis.Heliyon. 2022 Dec 25;9(3):e12583. doi: 10.1016/j.heliyon.2022.e12583. eCollection 2023 Mar. Heliyon. 2022. PMID: 37077375 Free PMC article.
-
Noncoding RNAs as Promising Diagnostic Biomarkers and Therapeutic Targets in Intestinal Fibrosis of Crohn's Disease: The Path From Bench to Bedside.Inflamm Bowel Dis. 2021 Jun 15;27(7):971-982. doi: 10.1093/ibd/izaa321. Inflamm Bowel Dis. 2021. PMID: 33324986 Free PMC article. Review.
-
Micro-Players of Great Significance-Host microRNA Signature in Viral Infections in Humans and Animals.Int J Mol Sci. 2022 Sep 11;23(18):10536. doi: 10.3390/ijms231810536. Int J Mol Sci. 2022. PMID: 36142450 Free PMC article. Review.
-
Serum non-coding RNAs for diagnosis and stage of liver fibrosis.J Clin Lab Anal. 2022 Oct;36(10):e24658. doi: 10.1002/jcla.24658. Epub 2022 Aug 21. J Clin Lab Anal. 2022. PMID: 35989522 Free PMC article. Review.
References
-
- Sterling RK, Lissen E, Clumeck N, et al. . APRICOT Clinical Investigators Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006; 43:1317–25. - PubMed
-
- Wai CT, Greenson JK, Fontana RJ, et al. . A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003; 38:518–26. - PubMed
-
- Kwok R, Tse YK, Wong GL, et al. . Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease–the role of transient elastography and plasma cytokeratin-18 fragments. Aliment Pharmacol Ther 2014; 39:254–69. - PubMed
-
- Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116:281–97. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources